294 related articles for article (PubMed ID: 8710868)
21. p53-dependent suppression of uridine phosphorylase gene expression through direct promoter interaction.
Zhang D; Cao D; Russell R; Pizzorno G
Cancer Res; 2001 Sep; 61(18):6899-905. PubMed ID: 11559567
[TBL] [Abstract][Full Text] [Related]
22. Regulation of insulin-like growth factor-I receptor gene expression by tumor necrosis factor-alpha and interferon-gamma.
Shalita-Chesner M; Katz J; Shemer J; Werner H
Mol Cell Endocrinol; 2001 May; 176(1-2):1-12. PubMed ID: 11369437
[TBL] [Abstract][Full Text] [Related]
23. Structural and functional analysis of the insulin-like growth factor I receptor gene promoter.
Werner H; Bach MA; Stannard B; Roberts CT; LeRoith D
Mol Endocrinol; 1992 Oct; 6(10):1545-58. PubMed ID: 1448110
[TBL] [Abstract][Full Text] [Related]
24. Adenoviral expression of p53 represses telomerase activity through down-regulation of human telomerase reverse transcriptase transcription.
Kanaya T; Kyo S; Hamada K; Takakura M; Kitagawa Y; Harada H; Inoue M
Clin Cancer Res; 2000 Apr; 6(4):1239-47. PubMed ID: 10778946
[TBL] [Abstract][Full Text] [Related]
25. Wild-type but not mutant p53 can repress transcription initiation in vitro by interfering with the binding of basal transcription factors to the TATA motif.
Ragimov N; Krauskopf A; Navot N; Rotter V; Oren M; Aloni Y
Oncogene; 1993 May; 8(5):1183-93. PubMed ID: 8479742
[TBL] [Abstract][Full Text] [Related]
26. Tumor-derived p53 mutants induce oncogenesis by transactivating growth-promoting genes.
Scian MJ; Stagliano KE; Deb D; Ellis MA; Carchman EH; Das A; Valerie K; Deb SP; Deb S
Oncogene; 2004 May; 23(25):4430-43. PubMed ID: 15077194
[TBL] [Abstract][Full Text] [Related]
27. Induction of the growth inhibitor IGF-binding protein 3 by p53.
Buckbinder L; Talbott R; Velasco-Miguel S; Takenaka I; Faha B; Seizinger BR; Kley N
Nature; 1995 Oct; 377(6550):646-9. PubMed ID: 7566179
[TBL] [Abstract][Full Text] [Related]
28. p53-independent activation of the hdm2-P2 promoter through multiple transcription factor response elements results in elevated hdm2 expression in estrogen receptor alpha-positive breast cancer cells.
Phelps M; Darley M; Primrose JN; Blaydes JP
Cancer Res; 2003 May; 63(10):2616-23. PubMed ID: 12750288
[TBL] [Abstract][Full Text] [Related]
29. Design of artificial transcription factors to selectively regulate the pro-apoptotic bax gene.
Falke D; Fisher M; Ye D; Juliano RL
Nucleic Acids Res; 2003 Feb; 31(3):e10. PubMed ID: 12560513
[TBL] [Abstract][Full Text] [Related]
30. ING1 represses transcription by direct DNA binding and through effects on p53.
Kataoka H; Bonnefin P; Vieyra D; Feng X; Hara Y; Miura Y; Joh T; Nakabayashi H; Vaziri H; Harris CC; Riabowol K
Cancer Res; 2003 Sep; 63(18):5785-92. PubMed ID: 14522900
[TBL] [Abstract][Full Text] [Related]
31. Insulin-like growth factor-i regulates Kruppel-like factor-6 gene expression in a p53-dependent manner.
Bentov I; Narla G; Schayek H; Akita K; Plymate SR; LeRoith D; Friedman SL; Werner H
Endocrinology; 2008 Apr; 149(4):1890-7. PubMed ID: 18174288
[TBL] [Abstract][Full Text] [Related]
32. Regulation of insulin-like growth factor I receptor promoter activity by wild-type and mutant versions of the WT1 tumor suppressor.
Tajinda K; Carroll J; Roberts CT
Endocrinology; 1999 Oct; 140(10):4713-24. PubMed ID: 10499530
[TBL] [Abstract][Full Text] [Related]
33. The MDR1 downstream promoter contains sequence-specific binding sites for wild-type p53.
Strauss BE; Shivakumar C; Deb SP; Deb S; Haas M
Biochem Biophys Res Commun; 1995 Dec; 217(3):825-31. PubMed ID: 8554604
[TBL] [Abstract][Full Text] [Related]
34. Estrogen receptor regulates insulin-like growth factor-I receptor gene expression in breast tumor cells: involvement of transcription factor Sp1.
Maor S; Mayer D; Yarden RI; Lee AV; Sarfstein R; Werner H; Papa MZ
J Endocrinol; 2006 Dec; 191(3):605-12. PubMed ID: 17170218
[TBL] [Abstract][Full Text] [Related]
35. The insulin-like growth factor-I receptor gene: a downstream target for oncogene and tumor suppressor action.
Werner H; Maor S
Trends Endocrinol Metab; 2006 Aug; 17(6):236-42. PubMed ID: 16815029
[TBL] [Abstract][Full Text] [Related]
36. Interaction of human polyomavirus BK with the tumor-suppressor protein p53.
Shivakumar CV; Das GC
Oncogene; 1996 Jul; 13(2):323-32. PubMed ID: 8710371
[TBL] [Abstract][Full Text] [Related]
37. Transcriptional regulation of basic fibroblast growth factor gene by p53 in human glioblastoma and hepatocellular carcinoma cells.
Ueba T; Nosaka T; Takahashi JA; Shibata F; Florkiewicz RZ; Vogelstein B; Oda Y; Kikuchi H; Hatanaka M
Proc Natl Acad Sci U S A; 1994 Sep; 91(19):9009-13. PubMed ID: 8090761
[TBL] [Abstract][Full Text] [Related]
38. Caveolin-1 up-regulates IGF-I receptor gene transcription in breast cancer cells via Sp1- and p53-dependent pathways.
Glait C; Tencer L; Ravid D; Sarfstein R; Liscovitch M; Werner H
Exp Cell Res; 2006 Nov; 312(19):3899-908. PubMed ID: 17014845
[TBL] [Abstract][Full Text] [Related]
39. Transcriptional repression by p53 involves molecular interactions distinct from those with the TATA box binding protein.
Farmer G; Friedlander P; Colgan J; Manley JL; Prives C
Nucleic Acids Res; 1996 Nov; 24(21):4281-8. PubMed ID: 8932384
[TBL] [Abstract][Full Text] [Related]
40. Transcriptional suppression of multidrug resistance-associated protein (MRP) gene expression by wild-type p53.
Wang Q; Beck WT
Cancer Res; 1998 Dec; 58(24):5762-9. PubMed ID: 9865734
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
